Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
SYROS PHARMAC.NEW DL-001
0S90Current price
1.54 EUR
+0.11 EUR (+7.69%)
Last closed
1.43 EUR
Company
–
ISIN
US87184Q2066
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
36 156 994 EUR
Yield for 12 month
-57.34 %
1Y
3Y
5Y
10Y
15Y
0S90
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts. Address: 35 CambridgePark Drive, Cambridge, MA, United States, 02140
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures 0S90
1 year
3 years
5 years
10 years
EBITDA
-115 105 272 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-51.11 %
PEG Ratio
–
Return On Equity TTM
-393.39 %
Wall Street Target Price
–
Revenue TTM
4 117 176 EUR
Book Value
-0.24 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-3.3 %
Dividend Yield
–
Gross Profit TTM
14 765 864 EUR
Earnings per share
-3.89 EUR
Diluted Eps TTM
-3.89 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 0S90
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 0S90
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
19.09.2022
Dividend Date
–
Stock Valuation 0S90
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
5.3458
Price Sales TTM
8.782
Enterprise Value EBITDA
-0.3863
Price Book MRQ
10.3252
Financials 0S90
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0S90
For 52 weeks
1.33 EUR
7.38 EUR
50 Day MA
3.69 EUR
Shares Short Prior Month
–
200 Day MA
4.93 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart